Market Tracker

04/17 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

During the Trading Day
34.58 -0.76 / -2.15%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.62 +0.04 / +0.12%
 
Volume: 1.7K
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close35.34
Today’s open35.14
Day’s range34.31 - 35.49
Volume365,300
Average volume (3 months)521,561
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+16.42%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio88.7
Price/Sales3.49
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.16-1.51%
MDCOMedicines Co-0.35-1.41%
ARNAArena Pharmaceutical...-0.12-1.90%
IPXLImpax Laboratories I...-0.39-1.60%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)$0.08
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts